ACTINIUM PHARMACEUTICALS, INC.

Profile

Company Names

ACTINIUM PHARMACEUTICALS, INC.
CACTUS VENTURES, INC.

Addresses

501 FIFTH AVENUE, 3RD FLOOR, NEW YORK, NY 10017

Phone Numbers

(212)300-2131
212-300-2131

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

NEVADA

Total Amount Raised:

$6,636,720.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2013-12-27 
$6,636,720.00 
$6,636,720.00 
$0.00 
Equity 
4
2013-09-25 
$0.00 
INDEFINITE 
INDEFINITE 
Equity 
3
2013-08-22 
$0.00 
INDEFINITE 
INDEFINITE 
Equity 
2
2013-03-11 
$0.00 
INDEFINITE 
INDEFINITE 
Equity 
1
2012-12-28 
$0.00 
INDEFINITE 
INDEFINITE 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DRAGAN 
 
CICIC 
EXECUTIVE OFFICER
ACTINIUM PHARMACEUTICALS, INC.   |  ACTINIUM PHARMACEUTICALS, INC.
KAUSHIK 
J. 
DAVE 
EXECUTIVE OFFICER, DIRECTOR
ACTINIUM PHARMACEUTICALS, INC.
DAVID 
 
NICHOLSON 
DIRECTOR
ACTINIUM PHARMACEUTICALS, INC.   |  ACTINIUM PHARMACEUTICALS, INC.   |  LA MEND, INC.   |  BABOON MEGA CORP, INC.   |  VOLASTRA THERAPEUTICS, INC.   |  RAPALOGIX HEALTH, INC.
SANDESH 
 
SETH 
DIRECTOR
ACTINIUM PHARMACEUTICALS, INC.   |  RELMADA THERAPEUTICS, INC.   |  ACTINIUM PHARMACEUTICALS, INC.   |  CAMP NINE, INC.
RICHARD 
I. 
STEINHART 
DIRECTOR
ACTINIUM PHARMACEUTICALS, INC.
JACK 
V. 
TALLEY 
EXECUTIVE OFFICER, DIRECTOR
ACTINIUM PHARMACEUTICALS, INC.   |  CACTUS VENTURES, INC.
SERGIO 
 
TRAVERSA 
EXECUTIVE OFFICER, DIRECTOR
ARDANA HEALTHCARE FUND LP   |  RELMADA THERAPEUTICS, INC.   |  ACTINIUM PHARMACEUTICALS, INC.   |  ACTINIUM PHARMACEUTICALS, INC.   |  CAMP NINE, INC.   |  RELMADA THERAPEUTICS, INC.   |  ENZETA IMMUNOTHERAPIES, INC.
SERGIO 
V. 
TRAVERSA 
EXECUTIVE OFFICER, DIRECTOR
CACTUS VENTURES, INC.   |  ACTINIUM PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2014-01-21
D/A
Link
PHARMACEUTICALS 
BLANK CHECKS [6770] 
NO REVENUES 
Equity 
2013-12-27 
2014-01-07
D
Link
PHARMACEUTICALS 
BLANK CHECKS [6770] 
NO REVENUES 
Equity 
2013-12-27 
2013-10-08
D
Link
PHARMACEUTICALS 
BLANK CHECKS [6770] 
NO REVENUES 
Equity 
2013-09-25 
2013-09-04
D
Link
PHARMACEUTICALS 
BLANK CHECKS [6770] 
NO REVENUES 
Equity 
2013-08-22 
2013-03-19
D
Link
PHARMACEUTICALS 
BLANK CHECKS [6770] 
NO REVENUES 
Equity 
2013-03-11 
2013-01-14
D
Link
PHARMACEUTICALS 
BLANK CHECKS [6770] 
NO REVENUES 
Equity 
2012-12-28 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
RECIPIENT LAIDLAW + COMPANY (UK) LTD.
119037